Ultrasound Detection of Epicardial Adipose Tissue Combined With Ischemic Modified Albumin in the Diagnosis of Coronary Heart Disease
Keywords:Coronary heart disease, echocardiography, epicardial adipose tissue, ischemic modified albumin, joint diagnosis
Objective: To evaluate the value of epicardial adipose tissue (EAT) thickness combined with serum ischemic modified albumin (IMA) concentration in the diagnosis of coronary heart disease.
Methods: A total of 180 patients with coronary heart disease from May 2017 to December 2018 were selected as the case group. After the examination of Judkins coronary angiography, they were grouped according to the results of angiography, including 60 patients in a single-vessel group,
60 patients in a double-vessel group, and 60 patients in a multi-vessel group. Sixty healthy people with physical examinations at our hospital at the same time were selected as the control group. All selected participants were tested for epicardial adipose tissue thickness by echocardiography and serum IMA concentration by albumin cobalt ion binding test.
Results: The EAT thickness and IMA concentration in the single-vessel disease group, double-vessel disease group, and multi-vessel disease group significantly were higher than those in the control group (P < .01). The ROC curve shows that the sensitivity is 53.33% and the specificity is 87.6%, when the EAT thickness is 6.12 mm. The sensitivity is 76.0% and the specificity is 72.3%, when the serum IMA concentration is 72 U/L. When the two were combined, the sensitivity was 40.15% and the specificity was 96.89%. In the parallel test, the sensitivity was 88.3% and the specificity was 65.44%.
Conclusion: Ultrasound detection of EAT thickness and serum IMA concentration has certain reference value for the diagnosis of coronary heart disease. Combined diagnosis can significantly improve the diagnosis rate and accuracy of coronary heart disease.
Faghihi S, Vasheghani-Farahani A, Parsaee M, et al. 2015. Association between epicardial fat thickness and premature coronary artery disease: a case control study . Res Cardiovasc Med 23, 4(2): e25679.
Falkner B, Lurbe E, Schaefer F, el a1. 2010. High blood pressure in childrenren: clinical and health policy implications. J Clin Hypertens 12(4): 261-27.
Gurumurthy P, Borra SK, Yeruva RK, et al. 2014. Estimation of Ischemia Modified Albumin (IMA) Levels in Patients with Acute Coronary Syndrome. Indian J Clin Biochem 29(3): 367-371.
Li J, Guo Q, Zhao J, et al. 2015. Correlation between epicardial fat density and coronary plaque. Chinese Journal of Clinical Medical Imaging 26(3): 179-182.
Mazzali G, Fantin F, Zoico E, et al. 2015. Heart fat infiltration in subjects with and without coronary artery disease. Clin Endocrinol Metab 100(9): 3364-3371.
Song X, Lu S. 2008. Evidence-based evaluation of the value of ischemic modified albumin in the diagnosis of myocardial ischemia in patients with coronary heart disease. Chinese Journal of Evidence-based Cardiovascular Medicine 1(1): 49-52.
Wang H. 2010. Vascular medicine: vascular health assessment and comprehensive prevention and treatment of vascular diseases. Chinese Journal of Medicine 90(30): 2092-2093.
Wang P, Zheng X, Wang Y. 2015. Relationship between serum ischemic modified albumin level and coronary artery lesions in patients with acute coronary syndrome. Chinese Journal of Evidence-based Cardiovascular Medicine 7(5): 650- 651.
Wang T, Liu Q, Pu Y, et al. 2014. Predictive value of epicardial adipose tissue for coronary heart disease. Chinese Journal of Arteriosclerosis 22(1): 61-64.
Xia H, Deng Y, Yang H, et al. 2011. Correlation analysis of high frequency ultrasound measurement of epicardial adipose tissue thickness and coronary heart disease risk factors. Chinese Journal of Ultrasonography 20(3): 197-200.
Yan H, Tang Y, Xu J. 2016. Clinical analysis of non-invasive detection of coronary atherosclerosis. Chinese Journal of Evidence-based Cardiovascular Medicine 8(8): 992-994.
Yuan C, Su Y, Ye S. 2014. Echocardiographic determination of epicardial fat thickness in the diagnosis of coronary heart disease. Clinician Medical Engineering, 21(6): 685-686.
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).